Brought to you by 
Rib-X Pharmaceuticals closes $25mm financing round
06 Feb 2009
Executive Summary
Antibiotics developer Rib-X Pharmaceuticals raised $25mm in its fourth financing round to returning shareholders ABS Ventures, Axiom Ventures, EuclidSR Partners, MedImmune Ventures, Oxford Bioscience Partners, SR One, Vox Equity Partners, and Warburg Pincus. The company raised a total of $135.5mm in its previous three rounds.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Rib-X Pharmaceuticals closes $25mm financing round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice